Sale!

CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test

Name: CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test
SKU: TEST-919
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the CYP4V2 gene, which are linked to Bietti Crystalline Corneoretinal Dystrophy (BCD). BCD is a rare genetic eye disorder characterized by the progressive loss of vision, the presence of crystal-like deposits in the retina, and the degeneration of the retina and choroid. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect specific genetic alterations in the CYP4V2 gene, helping in the diagnosis and management of the condition. By identifying the genetic basis of BCD, this test plays a crucial role in understanding the risk of disease progression, potential treatment approaches, and the likelihood of passing the condition to future generations.

Description

CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test

Test Name: CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Ophthalmology Disorders

Doctor: Ophthalmologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYP4V2 Gene Bietti Crystalline Corneoretinal Dystrophy NGS Genetic DNA Test gene CYP4V2

Test Details:

Bietti Crystalline Corneoretinal Dystrophy (BCD) is a rare genetic disorder that affects the retina and cornea of the eye. It is caused by mutations in the CYP4V2 gene, which provides instructions for making an enzyme that is involved in the breakdown of fatty acids in cells.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the CYP4V2 gene that are associated with BCD. This type of testing allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying genetic mutations that may be responsible for a particular disease or condition.

NGS genetic testing involves the use of high-throughput sequencing technologies to rapidly analyze large amounts of genetic data. This can help to identify mutations in the CYP4V2 gene that may be associated with BCD, and can provide valuable information for diagnosis, treatment, and genetic counseling.

Test Name	CYP4V2 Gene Bietti crystalline corneoretinal dystrophy Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Ophthalmology Disorders
Doctor	Ophthalmologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for CYP4V2 Gene Bietti crystalline corneoretinal dystrophy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYP4V2 Gene Bietti crystalline corneoretinal dystrophy NGS Genetic DNA Test gene CYP4V2
Test Details	Bietti crystalline corneoretinal dystrophy (BCD) is a rare genetic disorder that affects the retina and cornea of the eye. It is caused by mutations in the CYP4V2 gene, which provides instructions for making an enzyme that is involved in the breakdown of fatty acids in cells. NGS (next-generation sequencing) genetic testing can be used to identify mutations in the CYP4V2 gene that are associated with BCD. This type of testing allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying genetic mutations that may be responsible for a particular disease or condition. NGS genetic testing involves the use of high-throughput sequencing technologies to rapidly analyze large amounts of genetic data. This can help to identify mutations in the CYP4V2 gene that may be associated with BCD, and can provide valuable information for diagnosis, treatment, and genetic counseling.